Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 4/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.44 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
| ▸ | ADCYAP1R1 | P41586 | 1/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7736847 | 1.00 | MAOB (0.45) | MAOBHIF1ANR4A2MAPTHTT | |
| SCHEMBL7465781 | 0.92 | MAOB (0.47) | MAOBHIF1ANR4A2MAPTHTT | |
| SCHEMBL7462687 | 0.92 | MAOB (0.47) | MAOBHIF1ANR4A2MAPTHTT | |
| SCHEMBL7465783 | 0.92 | MAOB (0.47) | MAOBHIF1ANR4A2MAPTHTT | |
| SCHEMBL6839881 | 0.92 | HIF1A (0.53) | MAOBHIF1ANR4A2MAPTHTT | |
| SCHEMBL7493117 | 0.90 | MAOB (0.45) | MAOBHIF1ANR4A2MAPTHTT | |
| SCHEMBL7497699 | 0.90 | MAOB (0.45) | MAOBHIF1ANR4A2MAPTHTT | |
| SCHEMBL7497703 | 0.90 | MAOB (0.45) | MAOBHIF1ANR4A2MAPTHTT | |
| SCHEMBL7493118 | 0.90 | MAOB (0.45) | MAOBHIF1ANR4A2MAPTHTT | |
| SCHEMBL7500251 | 0.90 | HIF1A (0.57) | MAOBHIF1ANR4A2MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040039220-A1 | Process for the preparation of pesticides | FAROOQ SALEEM (CH) | 2004-02-26 | — | — | US | disclosed |
| US-6646151-B1 | Efficient oximation | BAYER AKTIENGESELLSCHAFT (DE) | 2003-11-11 | — | — | US | disclosed |
| EP-0876333-B1 | PROCESS FOR THE PREPARATION OF PESTICIDES | BAYER AG (DE) | 2002-03-27 | — | — | EP | disclosed |
| US-6156923-A | Process for the preparation of pesticides | NOVARTIS CORPORATION (US) | 2000-12-05 | — | — | US | disclosed |
| EP-0876333-A1 | PROCESS FOR THE PREPARATION OF PESTICIDES | Novartis AG (CH) | 1998-11-11 | — | — | EP | disclosed |
| WO-1997020808-A1 | PROCESS FOR THE PREPARATION OF PESTICIDES | NOVARTIS AG (CH) | 1997-06-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040039220-A1 | Process for the preparation of pesticides | CHRM1, CHRM2, F7 | MAOB 28/4885HIF1A 3590/4885NR4A2 1581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.